Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Targeted regulation of microRNA-125b may lead to effective prostate cancer therapies

A small, naturally occurring nucleic acid sequence, called a microRNA, known to regulate a number of different cancers, appears to alter the activity of the androgen receptor, which plays a critical role in prostate cancer.

18 Jul 2012

Combination of Dox with MCP shows promise against prostate cancer

Doxorubicin (Dox) is an effective anti-cancer drug, but it's also a very toxic one, causing severe heart and immune damage. The doses needed to impact tumors are not well tolerated by patients, however, researchers may have found an answer through combination therapy.

18 Jul 2012

Wake Forest, UCSD develop new genetic test for prostate cancer

Karim Kader, MD, PhD, associate clinical professor at the UC San Diego School of Medicine, together with a team of researchers from Wake Forest University School of Medicine, have developed a genetic test to predict a man's risk for prostate cancer. Use of the test could reduce the need for repeat biopsies in men who have had a negative biopsy.

18 Jul 2012

Johnson & Johnson second quarter sales decrease 0.7% to $16.5B

Johnson & Johnson today announced sales of $16.5 billion for the second quarter of 2012, a decrease of 0.7% as compared to the second quarter of 2011. Operational results increased 3.5% and the negative impact of currency was 4.2%.

17 Jul 2012

Tips to help minimize risks associated with acid reflux disease

While the overall death rates from several cancers such as breast and lung have gone down, there has been a meteoric rise in cases of esophageal cancer. Studies have shown that from 1975 to 2001, the incidence of esophageal adenocarcinoma rose approximately sixfold in the United States (from four to 23 cases per million), a relative increase greater than that for melanoma, breast, or prostate cancer.

17 Jul 2012

Prostate cancer treatment regrets linked to comorbidity

Men with cardiovascular disease are significantly more likely to regret their prostate cancer treatment choice than men without this comorbidity and have an increased risk for adverse effects, US researchers warn.

16 Jul 2012

Family physicians’ continuity of care pivotal in depressed terminally ill patients

The long-standing relationship between a family physician and his/her terminally ill patient is pivotal in the management of depression during palliative care, show Dutch study results.

12 Jul 2012

Collaboration is key to effective cancer palliation

Collaborative decision-making and frequent meetings between palliative care teams and oncology staff are the most critical factors for improving end-of-life care, say French researchers.

11 Jul 2012

Arrowhead initiates Adipotide Phase 1 trial in obesity

Arrowhead Research Corporation, a targeted therapeutics company, today announced that the first patient has been dosed in a Phase 1 clinical trial with Adipotide, a new class of treatment for obesity.

11 Jul 2012

Racial differences in hospice use revealed

Study results show that while hospice use by Medicare beneficiaries with heart failure increased in the USA over the period 2000 through 2008, non-White patients were less likely to enroll than their White counterparts.

10 Jul 2012

Scientists develop novel anticancer drug designed to travel through the bloodstream

Scientists at the Johns Hopkins Kimmel Cancer Center, working with Danish researchers, have developed a novel anticancer drug designed to travel -- undetected by normal cells -- through the bloodstream until activated by specific cancer proteins.

10 Jul 2012

Prostate patients make moves toward normality

A prompt return to usual daily activity is more likely for patients who have undergone radical prostatectomy if they start performing certain exercises soon after their operation, say researchers.

9 Jul 2012

Presence of SPDEF protein may predict prostate cancers that are unable to metastasize

Prostate cancer doesn't kill in the prostate - it's the disease's metastasis to other tissues that can be fatal. A University of Colorado Cancer Center study published this week in the Journal of Biological Chemistry shows that prostate cancer cells containing the protein SPDEF continue to grow at the same pace as their SPDEF- cousins, but that these SPDEF+ cells are unable to survive at possible sites of metastasis.

8 Jul 2012

23andMe identifies seven SNPs associated with breast size

Using data from its unique online research platform, 23andMe, a leading personal genetics company, has identified seven single-nucleotide polymorphisms (SNPs) significantly associated with breast size, including three SNPs also correlated with breast cancer in a genome-wide association study (GWAS) now published online in BMC Medical Genetics.

4 Jul 2012

Prostate cancer patients with CVD are 52% more likely to regret their treatment choices

Prostate cancer patients with cardiovascular disease were 52 per cent more likely to regret their treatment choices than men without problems with their heart or veins, according to a study published in the July issue of the urology journal BJUI International.

3 Jul 2012

Vitamin D–calcium combo reduces mortality in elderly

The results of a meta-analysis of individual patient data show that vitamin D supplementation with calcium reduces mortality rates in the elderly.

2 Jul 2012

Prostate Cancer Center of New Jersey earns ACR-ASTRO accreditation in radiation oncology

The Prostate Cancer Center of New Jersey, a partnership between AKSM/Oncology and the Urology Group of New Jersey (UGNJ), is the latest in a rapidly growing list of prostate-only treatment centers to earn the high honor of a three-year term of accreditation in radiation oncology.

2 Jul 2012

Blocking AXL protein may prevent resistance to lung cancer drug

People with lung cancer who are treated with the drug Tarceva face a daunting uncertainty: although their tumors may initially shrink, it's not a question of whether their cancer will return—it's a question of when. And for far too many, it happens far too soon.

2 Jul 2012

Enlightening risk factor findings for REM sleep behavior disorder

Cigarette smoking, head injury, farming, pesticide exposure, and a lower level of education may be risk factors for idiopathic rapid eye movement sleep behavior disorder, researchers report.

29 Jun 2012

Recurring diabetic foot ulcers ‘predictable’

The risk for recurring diabetic foot ulcers is predicted by clinical characteristics, such as existing ulcer location, bone infection, and diabetes control, demonstrates research published in International Wound Journal.

29 Jun 2012

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Targeted regulation of microRNA-125b may lead to effective prostate cancer therapies

Combination of Dox with MCP shows promise against prostate cancer

Wake Forest, UCSD develop new genetic test for prostate cancer

Johnson & Johnson second quarter sales decrease 0.7% to $16.5B

Tips to help minimize risks associated with acid reflux disease

Prostate cancer treatment regrets linked to comorbidity

Family physicians’ continuity of care pivotal in depressed terminally ill patients

Collaboration is key to effective cancer palliation

Arrowhead initiates Adipotide Phase 1 trial in obesity

Racial differences in hospice use revealed

Scientists develop novel anticancer drug designed to travel through the bloodstream

Prostate patients make moves toward normality

Presence of SPDEF protein may predict prostate cancers that are unable to metastasize

23andMe identifies seven SNPs associated with breast size

Prostate cancer patients with CVD are 52% more likely to regret their treatment choices

Vitamin D–calcium combo reduces mortality in elderly

Prostate Cancer Center of New Jersey earns ACR-ASTRO accreditation in radiation oncology

Blocking AXL protein may prevent resistance to lung cancer drug

Enlightening risk factor findings for REM sleep behavior disorder

Recurring diabetic foot ulcers ‘predictable’

What to know about prostate cancer eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

What to know about prostate cancer eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in